CME Group CME
CME Group scores good on business quality (6.9 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What CME Group does
CME Group operates global derivatives exchanges, making money by charging transaction fees on futures and options contracts traded by financial institutions and hedge funds. The firm recently shelved plans for a 24/7 crude oil contract, shifting focus to core liquidity windows.
- What it does best
CME dominates global benchmark futures trading, backed by an operating margin of 83.8%. This network effect creates massive switching costs for traders who refuse to fragment liquidity.
- The main risk
Regulatory shifts and failed product expansions pose direct threats, evidenced by the sudden suspension of its planned 24/7 crude oil contract which halts a potential volume growth vector.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin of 83.8% anchors an elite profitability profile, demonstrating strong operating leverage as trading volume scales.
Scale and deep liquidity form an exchange moat that locks in institutional market makers, supported by an operating margin in the top decile of its sector at 83.8%.
Revenue growth hit 17.1%, fueled by expanding trading volumes that significantly outpace its historical trajectory.
Interest coverage sits at 60.4x, making debt costs a rounding error while free cash flow reached $4.2B, pointing to a structurally softer balance sheet profile.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
1 insider bought $79K on the open market. 2 sold $4.3M outside pre-planned sales.
Our sealed record on CME
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
CME Group scores good on the Cluenex quality check (6.9 of 10), measured against its own industry. Profitability is strong, moat fair, growth fast and financial health fair.
In the last 90 days of SEC Form 4 filings: 1 insider bought $79K on the open market. 2 sold $4.3M outside pre-planned sales.
Oct 21, 2026, before the open.
See CME today
- Today's verdict on CME, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “CME Group (CME)”, https://cluenex.com/stocks/cme/, data as of Oct 10, 2026.